E-LIB Suche - Ergebnisse für: Kosloski, Matthew P.

1

Pharmacokinetics and pharmacodynamics of itepekimab in adul..:

Kosloski, Matthew P. ; Guttman‐Yassky, Emma ; Cork, Michael J....
Clinical and Translational Science. 17 (2024) 8 - p. , 2024

Link: https://doi.org/10.1111/..

2

Subcutaneous Administration of Monoclonal Antibodies: Pharm..:

Davis, John D. ; Bravo Padros, Marçal ; Conrado, Daniela J....
Clinical Pharmacology & Therapeutics. 115 (2024) 3 - p. 422-439 , 2024

Link: https://doi.org/10.1002/..

3

Dupilumab: Mechanism of action, clinical, and translational..:

McCann, Marc R. ; Kosloski, Matthew P. ; Xu, Christine..
Clinical and Translational Science. 17 (2024) 8 - p. , 2024

Link: https://doi.org/10.1111/..

4

AERIFY-1/-2: 2 phase 3 randomised controlled trials of itep..:

Rabe, Klaus F. ; Martinez, Fernando J. ; Bhatt, Surya P....
ERJ Open Research. , 2024

Link: https://doi.org/10.1183/..

5

Characterizing complex and competing drug–drug interactions..:

Kosloski, Matthew P. ; Li, Hong ; Wang, Stanley...
Clinical and Translational Science. 16 (2023) 4 - p. 593-605 , 2023

Link: https://doi.org/10.1111/..

6

Dupilumab Safety and Efficacy in a Phase III Open-Label Ext..:

Cork, Michael J. ; Thaçi, Diamant ; Eichenfield, Lawrence F....
Dermatology and Therapy. 13 (2023) 11 - p. 2697-2719 , 2023

Link: https://doi.org/10.1007/..

7

Integrated Exposure–Response of Dupilumab in Children, Adol..:

Briggs, Emily ; Kamal, Mohamed A. ; Kosloski, Matthew P....
Pharmaceutical Research. 40 (2023) 11 - p. 2653-2666 , 2023

Link: https://doi.org/10.1007/..

8

Pharmacokinetics of Subcutaneous Dupilumab Injection With a..:

Cohen, Yehuda Z. ; Zhang, Xiaojia ; Xia, Binfeng...
Clinical Pharmacology in Drug Development. 11 (2022) 5 - p. 675-681 , 2022

Link: https://doi.org/10.1002/..

9

Long-Term Efficacy and Safety of Dupilumab in Adolescents w..:

Blauvelt, Andrew ; Guttman-Yassky, Emma ; Paller, Amy S....
American Journal of Clinical Dermatology. 23 (2022) 3 - p. 365-383 , 2022

Link: https://doi.org/10.1007/..

10

Dupilumab in children aged 6 months to younger than 6 years..:

Paller, Amy S ; Simpson, Eric L ; Siegfried, Elaine C...
The Lancet. 400 (2022) 10356 - p. 908-919 , 2022

Link: https://doi.org/10.1016/..

11

Pharmacokinetics and pharmacodynamics of itepekimab in heal..:

Kosloski, Matthew P. ; Kalliolias, George D. ; Xu, Christine R....
Clinical and Translational Science. 15 (2021) 2 - p. 384-395 , 2021

Link: https://doi.org/10.1111/..

12

The Posology of Dupilumab in Pediatric Patients With Atopic..:

Kamal, Mohamed A. ; Kovalenko, Pavel ; Kosloski, Matthew P....
Clinical Pharmacology & Therapeutics. 110 (2021) 5 - p. 1318-1328 , 2021

Link: https://doi.org/10.1002/..

13

Effects of Rovalpituzumab Tesirine on Ventricular Repolariz..:

Goldman, Jonathan W. ; Barve, Minal ; Patel, Jyoti D....
Clinical and Translational Science. 14 (2020) 2 - p. 664-670 , 2020

Link: https://doi.org/10.1111/..

14

A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β D..:

Fleischmann, Roy M. ; Bliddal, Henning ; Blanco, Francisco J....
Arthritis & Rheumatology. 71 (2019) 7 - p. 1056-1069 , 2019

Link: https://doi.org/10.1002/..

15

Phase I safety and pharmacokinetics study of rovalpituzumab..:

Udagawa, Hibiki ; Akamatsu, Hiroaki ; Tanaka, Kentaro...
Lung Cancer. 135 (2019) - p. 145-150 , 2019

Link: https://doi.org/10.1016/..